State Street SPDR S&P Biotech ETF (XBI)
NYSE Arca · ETF
$150.94-2.15%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- Volume
- 7,124,487
- 52-week high
- —
- 52-week low
- —
- Open
- $154.64
- Day high
- $156.54
- Day low
- $150.89
Top holdings
| Holding | Name | Weight |
|---|---|---|
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.79% |
| ALKS | Alkermes PLC | 1.71% |
| TGTX | TG Therapeutics Inc | 1.52% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.51% |
| APGE | Apogee Therapeutics Inc | 1.49% |
| BEAM | Beam Therapeutics Inc | 1.42% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| NBIX | Neurocrine Biosciences Inc | 1.37% |
About State Street SPDR S&P Biotech ETF
SPDR Series Trust - State Street SPDR S&P Biotech ETF is an exchange traded fund launched by State Street Global Advisors, Inc. The fund is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Biotechnology Select Industry Index, by using representative sampling technique. SPDR Series Trust - State Street SPDR S&P Biotech ETF was formed on January 31, 2006 and is domiciled in the United States.